More Adalta Ltd. news Adalta Ltd.ASX: 1AD SYNThesis BioVentures MoU for cellular immunotherapies Apr 8, 2024 at 3:18 AM UTC · Issued by Adalta Ltd. As issuedPlain English Adalta Ltd has released a press release. View Attachment
